CIBC Asset Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $16.7M | Buy |
248,522
+27,164
| +12% | +$1.81M | 0.04% | 313 |
|
|
2026
Q1 | $13.9M | Buy |
221,358
+7,995
| +4% | +$557K | 0.03% | 315 |
|
|
2025
Q4 | $14.2M | Buy |
213,363
+57,178
| +37% | +$3.7M | 0.03% | 308 |
|
|
2025
Q3 | $10.5M | Buy |
156,185
+35,824
| +30% | +$2.83M | 0.03% | 297 |
|
|
2025
Q2 | $10.5M | Sell |
120,361
-5,806
| -5% | -$455K | 0.03% | 302 |
|
|
2025
Q1 | $8.62M | Buy |
126,167
+718
| +0.6% | +$58.6K | 0.03% | 324 |
|
|
2024
Q4 | $9.76M | Buy |
125,449
+1,558
| +1% | +$115K | 0.03% | 291 |
|
|
2024
Q3 | $8.31M | Buy |
123,891
+7,642
| +7% | +$628K | 0.03% | 314 |
|
|
2024
Q2 | $13.2M | Buy |
116,249
+2,541
| +2% | +$321K | 0.05% | 215 |
|
|
2024
Q1 | $15.8M | Buy |
113,708
+5,972
| +6% | +$751K | 0.05% | 208 |
|
|
2023
Q4 | $13.4M | Sell |
107,736
-205
| -0.2% | -$20.9K | 0.05% | 213 |
|
|
2023
Q3 | $10.1M | Buy |
107,941
+10,844
| +11% | +$1.22M | 0.04% | 235 |
|
|
2023
Q2 | $12.5M | Sell |
97,097
-537
| -0.6% | -$64.9K | 0.05% | 210 |
|
|
2023
Q1 | $11.3M | Buy |
97,634
+208
| +0.2% | +$23.3K | 0.05% | 221 |
|
|
2022
Q4 | $11M | Sell |
97,426
-1,133
| -1% | -$124K | 0.05% | 218 |
|
|
2022
Q3 | $7.94M | Buy |
98,559
+6,604
| +7% | +$559K | 0.03% | 256 |
|
|
2022
Q2 | $6.85M | Buy |
91,955
+11,255
| +14% | +$1.03M | 0.03% | 272 |
|
|
2022
Q1 | $10.3M | Buy |
80,700
+2,344
| +3% | +$256K | 0.04% | 236 |
|
|
2021
Q4 | $10.5M | Buy |
78,356
+7,544
| +11% | +$1.08M | 0.04% | 241 |
|
|
2021
Q3 | $9.68M | Buy |
70,812
+1,192
| +2% | +$150K | 0.04% | 238 |
|
|
2021
Q2 | $7.43M | Buy |
69,620
+3,048
| +5% | +$293K | 0.03% | 288 |
|
|
2021
Q1 | $5.98M | Buy |
66,572
+5,124
| +8% | +$481K | 0.03% | 302 |
|
|
2020
Q4 | $5.68M | Buy |
61,448
+4,096
| +7% | +$366K | 0.03% | 292 |
|
|
2020
Q3 | $5.91M | Buy |
57,352
+3,168
| +6% | +$331K | 0.03% | 264 |
|
|
2020
Q2 | $5.49M | Buy |
54,184
+40,888
| +308% | +$3.66M | 0.03% | 250 |
|
|
2020
Q1 | $895K | Sell |
13,296
-1,748
| -12% | -$109K | 0.01% | 529 |
|
|
2019
Q4 | $823K | Buy |
15,044
+556
| +4% | +$26.4K | ﹤0.01% | 642 |
|
|
2019
Q3 | $541K | Sell |
14,488
-956
| -6% | -$37.1K | ﹤0.01% | 698 |
|
|
2019
Q2 | $579K | Hold |
15,444
| – | – | ﹤0.01% | 714 |
|
|
2019
Q1 | $460K | Buy |
15,444
+2,704
| +21% | +$95K | ﹤0.01% | 745 |
|
|
2018
Q4 | $382K | Hold |
12,740
| – | – | ﹤0.01% | 737 |
|
|
2018
Q3 | $456K | Hold |
12,740
| – | – | ﹤0.01% | 747 |
|
|
2018
Q2 | $303K | Buy |
12,740
+852
| +7% | +$18.1K | ﹤0.01% | 828 |
|
|
2018
Q1 | $220K | Buy |
+11,888
| New | +$176K | ﹤0.01% | 936 |
|
|
2017
Q2 | – | Sell |
-10,624
| Closed | -$225K | – | 989 |
|
|
2017
Q1 | $225K | Buy |
+10,624
| New | +$207K | ﹤0.01% | 872 |
|
|
2016
Q4 | – | Sell |
-10,624
| Closed | -$233K | – | 964 |
|
|
2016
Q3 | $233K | Hold |
10,624
| – | – | ﹤0.01% | 847 |
|
|
2016
Q2 | $211K | Buy |
+10,624
| New | +$181K | ﹤0.01% | 866 |
|
|
2015
Q4 | – | Sell |
-9,572
| Closed | -$205K | – | 931 |
|
|
2015
Q3 | $205K | Buy |
+9,572
| New | +$214K | ﹤0.01% | 853 |
|
Other funds holding DXCM
CIBC Asset Management's DXCM Position: Q2 2026 in Review
CIBC Asset Management increased its DexCom (DXCM) stake by 12% in Q2 2026, buying an estimated $1.81M and bringing the position to 248,522 shares worth $16.7M. The position accounts for 0.04% of the portfolio, ranked #313.
CIBC Asset Management first reported a position in DXCM in Q3 2015 and has held it in 38 quarters since. 966 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- CIBC Asset Management held 248,522 shares of DexCom worth $16.7M as of Q2 2026.
- CIBC Asset Management bought 27,164 DexCom shares in Q2 2026, an estimated $1.81M.
- DexCom made up 0.04% of CIBC Asset Management's portfolio in Q2 2026, its #313 holding.
- CIBC Asset Management first reported a position in DexCom in Q3 2015 and has held it in 38 quarters since.
- 966 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on CIBC Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.